Semnur Pharmaceuticals, Inc. Business Development
Semnur Pharmaceuticals, Inc. (SMNR) had Business Development of $50.00 million as of 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2025-08-15
- 2025-06-30: Business Development $50.00M.
- 2025-03-31: Business Development $50.00M.
- 2024-10-02: Business Development $50.00M.
- 2024-02-22: Business Development $50.00M.
| Period end | Business Development |
|---|---|
| 2025-06-30 | $50.00M 10-Q · filed 2025-08-15 |
| 2025-03-31 | $50.00M 10-Q · filed 2025-05-16 |
| 2024-10-02 | $50.00M 10-Q · filed 2025-08-15 |
| 2024-02-22 | $50.00M 10-K · filed 2025-04-02 |